Skip to main content

CON-TGO91-321 - Sanofi-Aventis Australia Pty Ltd

Product names
  • AUST R 79021 - ISCOVER clopidogrel (as hydrogen sulfate) 75 mg tablet blister pack
  • AUST R 151257 - PLAVIX clopidogrel (as hydrogen sulfate) 300 mg tablet blister pack
  • AUST R 148947 - CLOPIDOGREL WINTHROP clopidogrel (as hydrogen sulfate) 75 mg tablet blister pack
Decision Date
Duration
The consent is effective for all batches manufactured between 1 September 2020 and 31 March 2021.
Non-compliance with standard

The product(s) do not conform with the requirements of TGO 91 but are supplied with label(s) that have been approved by the TGA.

Supply/Import or Export
Supply
Therapeutic good type
Prescription medicines

Help us improve the Therapeutic Goods Administration site